One really has to wonder whether we are still treating elderly men, initially diagnosed with organ-confined prostate cancer, with first-line or “primary” androgen deprivation therapy ADT)! And if we are, why on Earth is that? … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: ADT, androgen, appropriate, deprivation, elderly, organ-confined, primary | 4 Comments »
So a relatively new article in Reviews in Urology caught your Sitemaster’s eye this morning — and worried him because it seemed to be communicating a conclusion of questionable accuracy, which we will explore below. And if we have misinterpreted the data provide in the paper, we are more than willing to be corrected. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, elderly, Gleason score, PSA, risk, stage, Treatment | Leave a comment »
A group of Italian clinicians and researchers have reported that low-dose abiraterone acetate along with very low-dose prednisone appears to be both effective and safe in the treatment of elderly patients between 85 and 93 years of age with castration-resistant prostate cancer (CRPC). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: abiraterone, dose, elderly, food, prednisone | 9 Comments »
In a newly published article in the American Journal of Clinical Oncology, Mishra et al. have attempted to assess the application of immediate, first-line treatment among older men with favorable-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, decision, elderly, low, risk, Treatment, very lw | Leave a comment »
Now here’s a new perspective on the value of widespread prostate cancer screening from one of the founders of Prostate Cancer Awareness Week — Dr. David Crawford of the University of Colorado Health Science Center in Denver, CO (who is also the Chairman of the Prostate Conditions Education Council): … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: elderly, screening, testing, value | 2 Comments »
The value of regular testing of increasingly elderly men and women for risk of cancer is controversial. However, a new paper in the Archives of Internal Medicine has certainly added to our knowledge of just how widespread such testing may be … at least in the USA. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: elderly, recommendation, screening, testing | 9 Comments »
